Disease: Post-COVID-19

HOT-LoCO

Sweden
|
2021-2024
  • General population
  • Elderly
  • Adult
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Oxygen therapy

Prüßler

Germany
|
2023-2025
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Immunoadsorption

PROLIFIC

Sweden
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

Cathomas

Switzerland
|
2024-2028
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neuromodulation

GAT

Germany
|
2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Vocal-based therapy

STWandRVD

Italy
|
2023-2023
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Hydrotherapy

Koczulla

Germany
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Neurostimulation

Faulkner

United Kingdom
|
2022-2024
  • Adults
  • General population
  • Elderly
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Physical activity

CoviVa

Germany
|
2023-2027
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Neurostimulation

REMEDY

United Kingdom
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • Telemedicine
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Breathing therapy

Bellmann-Strobl

Germany
|
2023-2025
  • Adults
  • General population
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • vasodilator
  • Vericiguat

EJerSA-COVID-19

Spain
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Physical activity